Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Rob Shulman"'
Autor:
Jill J Francis, Eilidh M Duncan, Maria E Prior, Graeme S MacLennan, Stephan U Dombrowski, Geoff Bellingan, Marion K Campbell, Martin P Eccles, Louise Rose, Kathryn M Rowan, Rob Shulman, A Peter R Wilson, Brian H Cuthbertson
Publikováno v:
Health Technology Assessment, Vol 18, Iss 25 (2014)
Background: Hospital-acquired infections (HAIs) are a major cause of morbidity and mortality. Critically ill patients in intensive care units (ICUs) are particularly susceptible to these infections. One intervention that has gained much attention
Externí odkaz:
https://doaj.org/article/9d9b8dae24b24713a103f998e744bd4f
Autor:
Sara Polhill, Inês Pinheiro, Cecilia Montanari, Nishkantha Arulkumaran, Rob Shulman, Geoff Bellingan, Alessia Longobardo, Mervyn Singer, Suzanne Benhalm
Publikováno v:
The International Journal of Pharmacy Practice
Objectives Recent studies have demonstrated mortality benefits from corticosteroid use in COVID-19 patients requiring respiratory support. However, clinical practice may warrant the use of corticosteroids outside the context of a clinical trial. Such
Autor:
Mervyn Singer, Nishkantha Arulkumaran, Timothy A C Snow, Cecilia Montanari, Rob Shulman, Alessia Longobardo
Publikováno v:
Journal of Critical Care
Patients with COVID-19 ARDS have distinct physiological and immunological phenotypes compared to patients with non-COVID ARDS. Patients with COVID-19 ARDS (n = 32) had a significant improvement in PaO2: FiO2 ratio (p = 0.046) following low-dose stero
Autor:
Alessia Longobardo, Mervyn Singer, Nishkantha Arulkumaran, Rob Shulman, Cecilia Montanari, Suzanne Benhalim
Publikováno v:
BJA: British Journal of Anaesthesia
British Journal of Anaesthesia
British Journal of Anaesthesia
Autor:
Helen Taylor, Anja Richter, Caroline Edwards, Yogini Jani, Bryan O'Farrell, Meera Thacker, Rob Shulman, Ian Bates
Publikováno v:
International Journal of Pharmacy Practice. 24:253-261
ObjectivesTo evaluate the impact of a dedicated specialist critical care pharmacist service on patient care at a UK critical care unit (CCU).MethodsPharmacist intervention data was collected in two phases. Phase 1 was with the provision of a non-spec
Autor:
Henry Paw, Rob Shulman
Publikováno v:
Handbook of Drugs in Intensive Care. :407-408
Autor:
J Landa, Ian Bates, Andrew J. I. Jones, Catherine McKenzie, M Tomlin, Mark Borthwick, Richard S Bourne, Rob Shulman, D. West, Yogini Jani
Publikováno v:
Journal of Critical Care. 30:808-813
Purpose The purpose was to describe clinical pharmacist interventions across a range of critical care units (CCUs) throughout the United Kingdom, to identify CCU medication error rate and prescription optimization, and to identify the type and impact
Publikováno v:
The International journal of pharmacy practice. 26(6)
Background Medication errors are the most common type of medical errors critical care patients experience. Critical care units utilise a variety of resources to reduce medication errors; it is unknown which resources or combinations thereof are most
Autor:
R.R. Canter, S.E. Harvey, D.A. Harrison, M.K. Campbell, K.M. Rowan, B.H. Cuthbertson, Eilidh Duncan, Maria Prior, Geoff Bellingan, Marion Campbell, Martin Eccles, Marie Johnston, Graeme MacLennan, Craig Ramsay, Louise Rose, Kathy Rowan, Rob Shulman, Stephan Dombromski, Brian H. Cuthbertson
Publikováno v:
British Journal of Anaesthesia. 113:610-617
Background Evidence supporting selective decontamination of the digestive tract (SDD) is reasonably strong. We set out to determine use in UK critical care units and to compare patient outcomes between units that do and those that do not use SDD. Met
Publikováno v:
Journal of critical care, 41, 72-77. Elsevier BV
Purpose To audit the use of GIK in terms of safety, haemodynamic effects, and impact on catecholamine dosage. Materials and methods A retrospective, descriptive, evaluative audit of GIK use within the adult ICU of a London teaching hospital was condu